إعلان
إعلان
UPB
Upstream Bio, Inc. Common Stock
29.77
USDبرعاية
+2.23
+8.08%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
29.75
-0.01
-0.05%
تقارير أرباح UPB
النسبة الإيجابية المفاجئة
UPB تفوق 1 من 5 آخر التقديرات.
20%
التقرير التالي
بيانات التقرير القادم
١٠ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$614.41K
/-$0.68
التغير الضمني من Q3 25 (Revenue/ EPS)
-10.04%
/+7.94%
التغير الضمني من Q4 24 (Revenue/ EPS)
+0.23%
/-57.23%
Upstream Bio, Inc. Common Stock earnings per share and revenue
On ٠٥ نوفمبر ٢٠٢٥, UPB reported earnings of -0.63 USD per share (EPS) for Q3 25, beating the estimate of -0.78 USD, resulting in a 20.23% surprise. Revenue reached 683.00 ألف, compared to an expected 651.45 ألف, with a 4.84% difference. The market reacted with a -4.27% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 المحللين forecast an EPS of -0.68 USD, with revenue projected to reach 614.41 ألف USD, implying an زيادة of 7.94% EPS, and نقصان of -10.04% in Revenue from the last quarter.
الأسئلة الشائعة
What were Upstream Bio, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Upstream Bio, Inc. Common Stock reported EPS of -$0.63, beating estimates by 20.23%, and revenue of $683.00K, 4.84% above expectations.
How did the market react to Upstream Bio, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -4.27%, changed from $25.04 before the earnings release to $23.97 the day after.
When is Upstream Bio, Inc. Common Stock expected to report next?
The next earning report is scheduled for ١٠ مارس ٢٠٢٦.
What are the forecasts for Upstream Bio, Inc. Common Stock's next earnings report?
Based on 9
المحللين, Upstream Bio, Inc. Common Stock is expected to report EPS of -$0.68 and revenue of $614.41K for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان